Table 1 Patients and tumor characteristics (n = 40; 2005–2007)

1

62

female

clear cell

T1b

2

2

61

male

clear cell

T3b

2

3

64

male

clear cell

T4

3

4

69

female

clear cell

T1a

1

5

73

male

clear cell

T2b

4

6

62

female

clear cell

T3a

3

7

53

male

clear cell

T2b

2

8

57

male

clear cell

T3b

3

9

42

male

clear cell

T2b

3

10

64

male

clear cell

T2a

2

11

70

female

clear cell

T1b

2

12

68

female

clear cell

T3a

3

13

48

male

clear cell

T3a

3

14

78

male

clear cell

T1b

2

15

65

male

clear cell

T3a

3

16

38

female

clear cell

T3a

2

17

56

male

clear cell

T3b

3

18

44

female

clear cell

T3a

2

19

63

female

clear cell

T2a

1

20

69

male

clear cell

T4

2

21

55

male

clear cell

T3b

3

22

60

male

clear cell

T3a

2

23

38

female

clear cell

T1a

1

24

45

male

clear cell

T3b

2

25

62

female

clear cell

T3b

2

26

41

male

clear cell

T1b

3

27

60

female

clear cell

T2b

3

28

63

male

clear cell

T3b

2

29

35

male

clear cell

T1b

4

30

77

male

clear cell

T3a

3

31

64

male

clear cell

T2a

3

32

42

female

clear cell

T1a

1

33

68

female

clear cell

T3b

3

34

71

male

clear cell

T4

4

35

52

male

clear cell

T2b

2

36

62

female

clear cell

T3b

2

37

69

male

clear cell

T3a

3

38

73

male

clear cell

T3b

3

39

50

female

clear cell

T2a

2

40

38

male

clear cell

T1a

3